ix, 179 p. : 24 cm, Includes bibliographical references and index, Machine generated contents note: I Diagnosis of Pneumonia -- Jean-Yves Fagon and Jean Chastre -- 2, Diagnosis of Ventilator-Associated Pneumonia -- One American's Perspective -- Michael S. Niedenran -- Prevention of Pneumonia in Mechanically -- Ventilated Patients -- Jordi Valles -- 4, Is Prevention of Ventilator-Associated Pneumonia -- Cost Effective? -- Marin H. Kollef -- Role of the Oropharynx and Digestive Tract in -- the Pathogenesis of Ventilator-Associated Pneumonia -- Christianne A. van Nieuwenhoven and -- Marc J.M. Bonten -- B;6. Treatment of Ventilator-Associated Pneumonia -- European Perspective. -- .1. Sole-Violan, and -- F. Rodriguez de Castro -- 7. Treatment of Ventilator-Associated Pneumonia -- North American Perspective: -- Richard G. Wunderink -- 8. Resistant Pathogens: Emergence and Control -- in ICU Patients -- Jean Chastre -- 9. Resistant Pathogens: Emergence and Control -- Patricia Winokur, Carol E. Chenoweth, Louis Rice, -- Borna Mehrad, and Joseph P. Lynch, III -- 10. Mortality and Morbidity of Ventilator-Associated -- Pneumonia: The Controversy -- Jean Carlet, Jean-Francois Timsit, Benoit Misset, -- M. Garrouste, and L. Soufir -- INDEX

ia/ventilatorassoci0000unse.pdf

Ventilator-associated Pneumonia (perspectives On Critical Care Infectious Diseases)

Editor-richard D. Wunderink; Editor-jordi Rello

Richard G Wunderink; Jordi Rello

Kluwer Academic Publishers

Springer US

Perspectives on critical care infectious diseases, Boston [u.a, 2001

Perspectives on critical care infectious diseases, 4, Boston, ©2001

Perspectives on critical care infectious diseases, Boston, c2001

United States, United States of America

Springer Nature, New York, NY, 2012

Machine Generated Contents Note: I Diagnosis Of Pneumonia -- Jean-yves Fagon And Jean Chastre -- 2, Diagnosis Of Ventilator-associated Pneumonia -- One American's Perspective -- Michael S. Niedenran -- Prevention Of Pneumonia In Mechanically -- Ventilated Patients -- Jordi Valles -- 4, Is Prevention Of Ventilator-associated Pneumonia -- Cost Effective? -- Marin H. Kollef -- Role Of The Oropharynx And Digestive Tract In -- The Pathogenesis Of Ventilator-associated Pneumonia -- Christianne A. Van Nieuwenhoven And -- Marc J.m. Bonten -- B;6. Treatment Of Ventilator-associated Pneumonia -- European Perspective. -- 1. Sole-violan, And -- F. Rodriguez De Castro -- 7. Treatment Of Ventilator-associated Pneumonia -- North American Perspective: -- Richard G. Wunderink -- 8. Resistant Pathogens: Emergence And Control -- In Icu Patients -- Jean Chastre -- 9. Resistant Pathogens: Emergence And Control -- Patricia Winokur, Carol E. Chenoweth, Louis Rice, -- Borna Mehrad, And Joseph P. Lynch, Iii -- 10. Mortality And Morbidity Of Ventilator-associated -- Pneumonia: The Controversy -- Jean Carlet, Jean-francois Timsit, Benoit Misset, -- M. Garrouste, And L. Soufir -- Index. Edited By Richard G. Wunderink, Jordi Rello. Includes Bibliographical References And Index.

Ventilator-associated pneumonia (VAP) continues to be one of the greatest challenges to critical care practitioners and one of the greatest threats to the survival of our patients. The choice of this topic for an issue of the PERSPECTIVES IN CRITICAL CARE INFECTIOUS DISEASES Series is therefore quite appropriate. Despite its importance, many areas of the management of ventilator-associated pneumonia remain controversial. We therefore are pleased to include contributions from experts and investigators offering different perspectives on some of these controversial areas.

As stated in a recent editorial (1): "the diagnosis of nosocomial pneumonia has long been a subject of disagreement, with some intensivists relying on the use of bronchoscopic data to define the presence of lung infection and the responsible organisms, whereas others have used a combination of clinical diagnosis and tracheal aspirate cultures to achieve the same ends (2,3)".

Perspectives on Critical Care Infectious Diseases
Erscheinungsdatum: 31.10.2001

2023-06-28